Protagenic Therapeutics
€1.47
0
+€0+0% Friday 09:15
Statistics
Day High
1.47
Day Low
1.47
52W High
3.26
52W Low
1.18
Volume
-
Avg. Volume
0
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MBP.F. It's not an investment recommendation.
About
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
Show more...
CEO
Country
US
ISIN
US74365N2027
WKN
000A3D9TY